Eosinophilic granulomatosis with polyangiitis (EgPA) is a rare systemic small-and medium-sized-vessel vasculitis. The literature contains only a few reports of gastrointestinal perforation with this condition. We report a patient with EPgA treated with high-dose steroid who underwent emergency surgery for intestinal perforations. We performed a simple repair of the 11 perforations. Intestinal fistulas developed 8 d postoperatively; they healed well after 60 d of continuous washing and negative pressure suction. The clinical data of 14 additional patients with EgPA or Churg-Strauss syndrome complicated with gastrointestinal perforation, which were reported from 1996 to 2014, were also collected and compared. The formation of multiple perforations and fistulas following high dosage steroid administration can have a good outcome with appropriate management. Meticulous attention to abdominal symptoms and appropriate interventions can result in timely management. Corticosteroid administration remains a very important perioperative procedure for EPgA.
INTRODUCTION
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare type of necrotizing vasculitis affecting small to medium-sized vessels. It is typically characterized by asthma, lung infiltrates, necrotizing granulomas, and hypereosinophilia. It is an uncommon form of vasculitis with a prevalence that ranges from 10.7 to 13 cases/million [1] . Gastrointestinal involvement has been reported to occur in approximately 50% of EGPA patients. Symptoms include abdominal pain, vomiting and diarrhea [2] . Although EGPA very easily involves the digestive system, the chance of digestive tract perforation is very low and only a handful of cases have been reported. We report a case of EGPA with 11 intestinal perforations, and discuss the subsequent treatment.
CASE REPORT
A 43-year-old male with a 3-mo history of asthma was admitted to the Rheumatoid Immune Department of Shengjing Hospital in July 2013. The patient complained of a cough of one-month duration, blood-stained sputum, 14-d peripheral purpura, 3-d diarrhea, and an oral ulcer. His height was 176 cm and weight was 72 kg when admission. His temperature was 37.2 ℃, his pulse was 78 per minute, and his blood pressure was 128/78 mmHg. Multiple skin purpura was found in the physical examination. Heart sounds were clear and regular with no murmur. A few moist rales were heard with lung auscultation. Abdominal examination was unremarkable. Laboratory studies revealed leukocytosis (15600/mm 3 ) with eosinophilia (20.3%), a marked increase in inflammatory indices (ESR: 69 mm at the first hour; CRP: 176 mg/L), rheumatoid factor (656 UI/mL), and positive pANCA antibody. A pulmonary computed tomography (CT) scan revealed multiple lowdensity oval shadows, with the largest one measuring about 3.2 cm × 2.6 cm ( Figure 1) . A diagnosis of vasculitis was made. A biopsy of the nasal mucosa revealed an eosinophilic infiltration. We diagnosed EGPA according to the revised international Chapel Hill nomenclature. The patient received methylprednisolone (120 mg intravenously daily) and ifosfamide for the treatment of the pulmonary lesions. The patient's condition exacerbated during the first three days follow ing admission; the methylprednisolone dose was increased to 500 mg (intravenously daily × 2) and then was gradually tapered. On the 13 th day after admission (160 mg methylprednisolone intravenously daily), he experienced a sudden onset of fever and abdominal pain. The physical examination revealed generalized abdominal tenderness without apparent rebound tenderness, and muscle tension. No specific treatment was given. After 11 h, the abdominal pain exacerbated and peritonitis developed. An abdominal CT scan showed an amount of free gas in the abdominal cavity (Figure 2) . A laparotomy was performed immediately, which revealed scattered eleven perforations in the intestine. The proximal one was located approximately 150 cm distal from the ligament of Treitz ligament, and the distal one located approximately 50 cm from the ileocecal valve, with the largest measuring about 3 cm × 3 cm ( Figure  3 ). Considering the high risk of short bowel syndrome, we made a simple repair of the intestinal perforations. Histopathological examination did not reveal either eosinophilic infiltration or granuloma formation of the vessels ( Figure 4 ). Continued intravenous therapy with intermittent ifosfamide as well as somatostatin and esomeprazole was administered postoperatively. The hormone dosage was tapered from 160 mg downward. On postoperative day 6, when the steroid was reduced to 80 mg, the patient's vasculitis exacerbated and he developed fever and new purpura on the entire body. Eight days postoperatively, an intestinal fistula developed, which was confirmed by fistulography ( Figure 5 ). With continuous saline washing through a double-lumen cannula connected to a negative pressure suction apparatus, the drainage was about 300 mL intestinal fluid daily; the fistula slowly healed. The patient began eating on postoperative day 45. Gastric retention occurred after eating; it was treated with decompression via a nasogastric tube, total parenteral nutrition, and a gastric motility stimulating agent. The patient resumed eating about two months postoperatively, and the drainage was minimal. When the steroid dosage was reduced to 60 mg intravenously, the fistula healed and the patient was discharged.
Unfortunately, four months later, an intestinal fistula and vasculitis recurred. Although the amount was 5 mL daily, he was readmitted and underwent continuous washing and negative pressure suction. The fistula healed slowly during one month. When last seen in the outpatient clinic in March 2014, he was in good health without any symptoms or eosinophilia. Laboratory analysis revealed 0.1% eosinophils and negative pANCA antibodies.
DICUSSION
EGPA, formerly named churg-strauss syndrome (CSS), is characterized by the presence of severe asthma as well as blood and tissue eosinophilia. It is an uncommon form of vasculitis, with a prevalence that ranges from 10.7 to 13 cases/million. Although it is classified as vasculitis, the affected tissue usually does not show necrotizing vasculitis or granulomata, rather an apparently nondestructive infiltration of the vessel walls by eosinophils; in fact, only 40%-60% of patients with CSS have anti-neutrophil cytoplasmic antibodies (ANCAs) [3] . For this reason the diagnostic criteria remain clinical.
Gastrointestinal involvement is present in 32.6% of CSS patients. In 29.11% of the cases, the large bowel is involved, in 53.5%, the small bowel is involved, in 16.6%, the gastroduodenal region is involved, and in 6.3%, pancreatitis and cholecystitis occur. The mortality rate is 11.9% [4] [5] [6] . Although gastrointestinal symptoms are common, perforated ulcers are relatively uncommon and only a small number of cases have been documented in the literature [7] . Because multiple organs are involved and peritonitis symptoms are not typical, complicated clinical manifestations occur, which delays Assmann et al [12] 2014 36/ male Dyspnea, fatigue, fever and chest pain -4900/l Yes + cyclophosphamide
Colon transversum Anastomosis Eosinophilic infiltration and thrombotic vessel occlusion No Alive
Çiledağ et al [8] 2012 35/ male
Venditti et al [13] 2011 69/ male Murakami et al [5] 2004 51/ female A systematic review of the literature was performed using the keywords "Churg-Strauss syndrome/eosinophilic granulomatosis with polyangiitis" and "gastrointestinal perforation" in PubMed to search articles from 1951 to December 2014. In China, CSS/EGPA with gastrointestinal perforation is very rare, and there is no relevant report. The articles were restricted to English language only. Duplicate reports and papers with important data missing were excluded. We included the papers on digestive tract perforation with CSS/EGPA, and compared the characteristics ( Table 1 ). The average patient age was 46.3 years (range: 1672 years; males: 10; females: 4). A half of the patients were complicated with the symptom of asthma, and all of them had received corticosteroid treatment. Their prognosis was poor, with 4/13 (30.77%; case 13 was unknown) dying during hospitalization, although the causes of death were very different. A second perforation of the digestive system occurred in 2 (15.38％) of 13 patients (case 13 was unknown).
Ulceration, perforation, and stenosis of the gastrointestinal tract are assumed to be the results of ischemia caused by vasculitis. The small intestine is the most commonly affected site [8] . Immunosuppressive therapy, especially large-dosage corticosteroids, may play an important role in the development of an intestinal perforation. However, sometimes, it is difficult to distinguish clinically whether the intestinal perforation is due to vasculitis itself or immunosuppression [9] . Treatment of a gastrointestinal perforation in patients with active vasculitis can be challenging. A delayed diagnosis may lead to a delayed cure, as in our patient. First, we did not pay adequate attention to the digestive symptoms: Sour regurgitation, heartburn, and abdominal pain. Second, the symptoms of peritonitis are often atypical in patients receiving longterm administration of glucocorticoids. Third, when the digestive tract perforation occurred, the patient was in the rheumatic ward. As a result of consultation, diagnosis, and department transference, treatment delay can occur. Fourth, the gastrointestinal perforation may occur during a clinical remission. The perforation of this case occurred during the process of steroid tapering. Pathologic examination of the perforated bowel revealed no significant eosinophil infiltration.
In conclusion, improved awareness of gastrointestinal symptoms may allow for timely management of a perforation. Multiple perforations and fistulas caused by high dosage steroids can have a good outcome with appropriate management. Prompt surgical treatment is necessary. The choice of the appropriate surgical approach should be based on the time the perforations occurred, their size, numbers, and sites. Adequate steroid administration and intensive care play an important role during perioperative treatment.
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Case characteristics
A 43-year-old male with a 3-mo history of asthma, a cough of one-month duration, blood-stained sputum, 14 d of peripheral purpura, 3 d of diarrhea, and an oral ulcer. On the 13 th day after admission, the patient experienced a sudden onset of fever and abdominal pain. And the abdominal pain exacerbated and peritonitis developed rapidly.
Clinical diagnosis
history of asthma, peripheral purpura, and peritonitis.
Differential diagnosis
Granulomatosis with polyangiitis, microscopic polyangitis, and polyarteritis nodosa.
Laboratory diagnosis
Laboratory studies revealed leukocytosis (15600/mm 3 ) with eosinophilia (20.3%), a marked increase in inflammatory indices (ESR: 69 mm at the first hour; CRP: 176 mg/l), rheumatoid factor (656 UI/ml), and positive pANCA antibody.
Imaging diagnosis
A pulmonary computed tomography (CT) scan revealed multiple low-density oval shadows, with the largest one measuring about 3.2 cm × 2.6 cm. An abdominal CT scan showed free air in the abdomen.
Pathological diagnosis
A biopsy of the nasal mucosa revealed an eosinophilic infiltration.
Treatment
Continued intravenous hormone therapy with intermittent ifosfamide Sharma et al [19] 1996 16 Figure 5 Fistulography showing that after injection of contrast agents, the intestine of the right lower quadrant abdomen developed a fistula.
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